Industrial partners
Coris BioConcept
DZIF scientists from the Institute of Medical Microbiology, Immunology and Hygiene at the University of Cologne have generated antibodies against the carbapenemases OXA-23, -40 and -58, which are being used in collaboration with the Belgian company Coris BioConcept in a now commercially available rapid test for the detection of carbapenem-resistant Acinetobacter baumannii.